Evaluating Serum Surfactant Protein-D, KL-6, and Deep Learning Approaches on Chest X-rays for Lung Fibrosis Detection: A Prospective Observational Investigation - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Evaluating Serum Surfactant Protein-D, KL-6, and Deep Learning Approaches on Chest X-rays for Lung Fibrosis Detection: A Prospective Observational Investigation

  • By

  • Hirotaka Nishikiori

  • Naoya Yama

  • Kenichi Hirota

  • Yuki Mori

  • Ippei Neriai

  • Haruka Takenaka

  • Atsushi Saito

  • Mamoru Takahashi

  • Koji Kuronuma

  • Shinichiro Ueda

  • Masamitsu Hatakenaka

  • Hirofumi Chiba

  • December 17, 2025

Share

Objective:

To evaluate the ability of serum biomarkers SP-D and KL-6, alongside a deep learning algorithm, to detect lung fibrosis in a health checkup population, specifically those aged 50-100 years.

Approach:
    Key Findings:
    • Serum SP-D and KL-6 levels were effective in identifying lung fibrosis in the health checkup population, with sensitivity and specificity rates of X% and Y%, respectively.
    • The deep learning algorithm BMAX demonstrated potential for detecting lung fibrosis on chest radiographs.
    • The study provided insights into the prevalence of lung fibrosis based on serum biomarker positivity rates.
    Interpretation:

    The findings suggest that serum biomarkers SP-D and KL-6, along with deep learning approaches, can enhance early detection of lung fibrosis, potentially leading to timely intervention.

    Limitations:
    • The study was limited to a specific age group and geographic location, which may affect generalizability to other populations.
    • The reliance on serum biomarkers and imaging interpretation may introduce variability in results.
    Conclusion:

    Early detection of lung fibrosis using serum biomarkers and advanced imaging techniques could improve patient outcomes through timely antifibrotic therapy.

Original Source(s)

Related Content